NASDAQ:LPCN

Lipocine Stock Predictions

Healthcare > Biotechnology

Buy LPCN

*Your capital is at risk

$2.19

-0.0600 (-2.67%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LPCN Prediction Chart

LPCN Predictions History

Latest community submissions for LPCN.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Alan Pro @Alan.115878	Dec 21, 2020	$1.38 -94.28%	$1.42	V	97.18%	0
JS Pro	Dec 8, 2020	$1.66 -94.19%	$1.68	V	98.81%	2
JS Pro	Nov 25, 2020	$1.57 -94.33%	$1.63	V	96.32%	0
JS Pro	Nov 24, 2020	$1.54 -94.30%	$1.59	V	96.86%	0
sander7100 yo bro Pro @sander7100yobro.167552	Jul 28, 2020	$1.53 -94.08%	$1.52	X	99.34%	4
JS Pro	Jul 28, 2020	$1.40 -94.58%	$1.52	V	92.11%	0
Karim.A..Serageldin.104471 Amateur	Jul 28, 2020	$1.47 -94.31%	$1.52	X	96.71%	1
sander7100 yo bro Pro @sander7100yobro.167552	Jul 27, 2020	$1.51 -93.83%	$1.44	X	95.14%	0
JS Pro	Jul 27, 2020	$1.44 -94.12%	$1.44	V	100.00%	10
Karim.A..Serageldin.104471 Amateur	Jul 27, 2020	$1.50 -93.87%	$1.44	X	95.83%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LPCN with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT LIPOCINE INC.

Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioident...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by